文献速递炎症性肠病消化内镜消化道肿瘤与早癌

溃疡性结肠炎患者结直肠肿瘤内镜下切除的有效性:一项多中心注册研究

Effectiveness of endoscopic resection for colorectal neoplasms in ulcerative colitis: a multicenter registration study.
PubMed 文献 · Gastrointest Endosc · 2023-05-30

这项回顾性多中心队列研究纳入2015年4月至2021年3月因结直肠肿瘤初次接受内镜下切除或手术的溃疡性结肠炎患者,排除既往有结直肠肿瘤病变者。共分析213例男性与123例女性,EMR治疗142处病变、ESD治疗96处病变,穿孔率2.5%(238处内镜切除病变)、ESD穿孔率6.3%(96处病变),局部复发率2.7%(146处内镜随访病变),异时性肿瘤发生率6.1%。作者认为内镜下切除在选择性病例中或可接受,但需随访异时性病变。

要点

  • 内镜下切除238处病变总体穿孔率2.5%,其中ESD切除96处病变穿孔率6.3%。
  • 内镜随访的146处切除病变局部复发率2.7%,内镜切除后异时性肿瘤发生率6.1%。
  • 作者认为内镜下切除在选择性病例中或可接受,但需随访异时性病变。

核心结论

  • 作者认为,溃疡性结肠炎患者结直肠肿瘤的内镜下切除在选择性病例中或可接受,但需对异时性病变进行随访。

研究设计与样本

  • 回顾性多中心队列研究,纳入2015年4月至2021年3月因结直肠肿瘤初次接受内镜下切除或手术的溃疡性结肠炎患者,排除既往有结直肠肿瘤病变者。
  • 共分析213例男性与123例女性,溃疡性结肠炎发病平均年龄41.6岁,肿瘤诊断平均年龄56.1岁。

主要发现

  • 病变范围包括全结肠炎240例、左半结肠炎59例、直肠炎31例、节段性结肠炎6例。
  • EMR治疗142处病变,ESD治疗96处病变。
  • 全部238处内镜切除病变穿孔率2.5%,ESD切除的96处病变穿孔率6.3%。
  • 146处内镜随访的内镜切除病变局部复发率2.7%,内镜切除后异时性肿瘤发生率6.1%。
  • 全部患者初次治疗后中位随访34.7个月,5例死亡(均为手术病例),内镜切除组总生存率显著高于手术组(P = .0085)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with ulcerative colitis (UC) are at risk of developing colorectal cancer. The feasibility of endoscopic resection (ER) for UC-associated neoplasia has been suggested, but its efficacy and safety remain unclear. We aimed to assess the efficacy and safety of ER for colorectal neoplasms in patients with UC. METHODS: This was a retrospective, multicenter cohort study of patients with UC who initially underwent ER or surgery for colorectal neoplasms between April 2015 and March 2021. Patients who had prior colorectal neoplastic lesions were excluded. RESULTS: Among 213 men and 123 women analyzed, the mean age at UC onset was 41.6 years, and the mean age at neoplasia diagnosis was 56.1 years for 240 cases of total colitis, 59 cases of left-sided colitis, 31 cases of proctitis, and 6 cases of segmental colitis. EMR was performed for 142 lesions, and endoscopic submucosal dissection (ESD) was performed for 96 lesions. The perforation rate was 2.5% for all 238 lesions removed by ER and 6.3% for the 96 lesions removed by ESD. Among 146 ER lesions followed up with endoscopy, the local recurrence rate was 2.7%. The incidence of metachronous neoplasia after ER was 6.1%. All patients were followed a median of 34.7 months after initial treatment, and 5 died (all surgical cases). Overall survival was significantly higher in the ER group than in the surgery group (P = .0085). CONCLUSIONS: ER for colorectal neoplasms in UC may be acceptable in selected cases, although follow-up for metachronous lesions is necessary.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Hirai M, Yanai S, Kunisaki R, et al. Effectiveness of endoscopic resection for colorectal neoplasms in ulcerative colitis: a multicenter registration study. Gastrointest Endosc. 2023. PMID: 37263363. doi:10.1016/j.gie.2023.05.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。